Topic

Therapeutic Steady

16,842 applications whose title mentions it. Its share of new filings over the last two years is -7% below the four years before.

Allowance rate

57%

−18 pts vs the USPTO 14,542 decided

Months to first action

18.5 mo

−0.1 vs the USPTO

Applications

16,842.0

in the record

Allowed

8,276.0

6,266 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Where it is examined

Domains and art units

CPC subclasses

A61K6,926 apps

C07K1,364 apps

C07D1,279 apps

A61M743 apps

C12N741 apps

A61B717 apps

Art units

OPAP775 apps

1627497 apps

1626492 apps

1625465 apps

1629426 apps

1628416 apps

Examiners

Who examines it, and how it fares with each

Docket Central779 apps

Niloofar Rahmani99 apps

86%

Samantha L Shterengarts93 apps

85%

Amy Rose Hudson84 apps

72%

Kristin Ann Vajda66 apps

89%

Golam M Shameem65 apps

84%

Phuong N Huynh62 apps

67%

Michael P Barker58 apps

89%

Bars show the share of decided applications that were allowed.

Unlock the examiners behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who files it

Companies and institutions

SANOFI226 apps

81%

NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT170 apps

59%

Allergan, Inc.151 apps

73%

The Regents of the University of California114 apps

57%

Genentech, Inc.99 apps

38%

LTS LOHMANN THERAPIE-SYSTEME AG86 apps

69%

Bars show the share of decided applications that were allowed.

Unlock the filers behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents

FOLEY & LARDNER LLP319 apps

57%

Knobbe, Martens, Olson & Bear, LLP273 apps

62%

COOLEY LLP264 apps

56%

WILSON SONSINI GOODRICH & ROSATI218 apps

55%

ALLERGAN, INC.213 apps

77%

OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P.189 apps

55%

Bars show the share of decided applications that were allowed.

Unlock the firms behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Applications

Recent applications on this topic

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19628820	THERAPEUTIC ANTIBODY EPITOPE-TAGGED CAR T CELLS FOR ENHANCED CONTROL AND SAFETY	2026-09-28	Pending	0	0	n/a
19628462	SPLICE-SWITCHING OLIGONUCLEOTIDES TARGETING INSULIN RECEPTOR AS A CANCER THERAPEUTIC	2026-09-25	Pending	0	0	n/a
19627864	THERAPEUTIC USE OF FIBROBLASTS FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS	2026-09-24	Pending	0	0	n/a
15605354	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15124272	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15267036	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15339814	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15937263	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15977240	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15108004	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in